BIOTU
Biotech Acquisition Company Unit
BIOTU
BIOTU
Delisted
BIOTU was delisted on the 2nd of February, 2023.
5 hedge funds and large institutions have $517K invested in Biotech Acquisition Company Unit in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
1
Clear Street
New York
|
$112K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$5K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $397K | 40,000 | – | – |
|
|
CS
2
Clear Street
New York
| $112K | 11,291 | +11,284 | +161,200% |
|
|
3
Morgan Stanley
New York
| $5K | 551 | -4,296 | -89% |
|
4
UBS Group
Zurich,
Switzerland
| $2K | 210 | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1K | 103 | – | – |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|